Eric Wang ewang@skingenixweb.com & | Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, clinical research, drug development, and FDA regulatory affairs in academic and industrial settings. Educated as a medical doctor at China Medical University (Shenyang, China, 1981-1986) and trained as a pulmonary disease specialist at Dalian Medical University (Dalian, China, 1986-1989), Wang began his career as a physician at Dalian Medical University Hospital. From 1994 to 1996, sponsored by Japan-China Medical Association, Wang received clinical training in pulmonary infections at Nagasaki University Medical School in Japan. Later, he studied Medical Product Development and Regulatory Science at University of California, Irvine from 2000 to 2004. Having been working in the pharmaceutical industry in Southern California since 1996, he has been actively engaged in the areas of R&D, quality, regulatory affairs, clinical development, and strategic planning for company's drug development programs. Currently, he serves as a Board member and Chief Operating Officer of RegenIntel Bioscience, Inc. (Brea, CA) and Executive Vice President of Skingenix, Inc. (Ontario, CA). Wang is a certified clinical research and FDA regulatory affair professional. Wang also serves as Advisory Board member of Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School.

Eric Wang

Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, clinical research, drug...

21240 Corral Court, Walnut, United States

*50 free lookup(s) per month.

No credit card required.

Eric Wang’s Emails [email protected]

Eric Wang’s Phone Numbers No phone number available.

Social Media

Eric Wang’s Location 21240 Corral Court, Walnut, United States

Eric Wang’s Expertise Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, clinical research, drug development, and FDA regulatory affairs in academic and industrial settings. Educated as a medical doctor at China Medical University (Shenyang, China, 1981-1986) and trained as a pulmonary disease specialist at Dalian Medical University (Dalian, China, 1986-1989), Wang began his career as a physician at Dalian Medical University Hospital. From 1994 to 1996, sponsored by Japan-China Medical Association, Wang received clinical training in pulmonary infections at Nagasaki University Medical School in Japan. Later, he studied Medical Product Development and Regulatory Science at University of California, Irvine from 2000 to 2004. Having been working in the pharmaceutical industry in Southern California since 1996, he has been actively engaged in the areas of R&D, quality, regulatory affairs, clinical development, and strategic planning for company's drug development programs. Currently, he serves as a Board member and Chief Operating Officer of RegenIntel Bioscience, Inc. (Brea, CA) and Executive Vice President of Skingenix, Inc. (Ontario, CA). Wang is a certified clinical research and FDA regulatory affair professional. Wang also serves as Advisory Board member of Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School.

Eric Wang’s Current Industry Regenintel Bioscience

Not the Eric Wang you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Regenintel Bioscience

Co-Founder & Coo

Thu Jun 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Center For Regenerative Therapeutics At Bidmc Harvard Medical School

Advisory Board Member

Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Skingenix

Executive Vice President

Sun Jan 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Phytoscience And Technology

Vice President, R&D

Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jan 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time)

Naturepharm

Director, R&D

Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)

N And N

Senior Project Manager, R&D

Mon Jan 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jan 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time)

Nagasaki University Hospital

Biomedical Researcher

Sat Jan 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 1996 00:00:00 GMT+0000 (Coordinated Universal Time)

Dalian Medical University Hospital

Resident, Physician In Charge, Associate Professor

Wed Jan 01 1986 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 1994 00:00:00 GMT+0000 (Coordinated Universal Time)

Skills

Languages

FAQ About Eric Wang

Eric Wang is located at
21240 Corral Court, Walnut, United States

Eric Wang is a
Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, clinical research, drug development, and FDA regulatory affairs in academic and industrial settings. Educated as a medical doctor at China Medical University (Shenyang, China, 1981-1986) and trained as a pulmonary disease specialist at Dalian Medical University (Dalian, China, 1986-1989), Wang began his career as a physician at Dalian Medical University Hospital. From 1994 to 1996, sponsored by Japan-China Medical Association, Wang received clinical training in pulmonary infections at Nagasaki University Medical School in Japan. Later, he studied Medical Product Development and Regulatory Science at University of California, Irvine from 2000 to 2004. Having been working in the pharmaceutical industry in Southern California since 1996, he has been actively engaged in the areas of R&D, quality, regulatory affairs, clinical development, and strategic planning for company's drug development programs. Currently, he serves as a Board member and Chief Operating Officer of RegenIntel Bioscience, Inc. (Brea, CA) and Executive Vice President of Skingenix, Inc. (Ontario, CA). Wang is a certified clinical research and FDA regulatory affair professional. Wang also serves as Advisory Board member of Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School. Regenintel Bioscience

Eric Wang currently works in the
Regenintel Bioscience

Eric Wang specializes in
Eric Wang is a senior executive professional with over 30 years’ experience in clinical practice, clinical research, drug development, and FDA regulatory affairs in academic and industrial settings. Educated as a medical doctor at China Medical University (Shenyang, China, 1981-1986) and trained as a pulmonary disease specialist at Dalian Medical University (Dalian, China, 1986-1989), Wang began his career as a physician at Dalian Medical University Hospital. From 1994 to 1996, sponsored by Japan-China Medical Association, Wang received clinical training in pulmonary infections at Nagasaki University Medical School in Japan. Later, he studied Medical Product Development and Regulatory Science at University of California, Irvine from 2000 to 2004. Having been working in the pharmaceutical industry in Southern California since 1996, he has been actively engaged in the areas of R&D, quality, regulatory affairs, clinical development, and strategic planning for company's drug development programs. Currently, he serves as a Board member and Chief Operating Officer of RegenIntel Bioscience, Inc. (Brea, CA) and Executive Vice President of Skingenix, Inc. (Ontario, CA). Wang is a certified clinical research and FDA regulatory affair professional. Wang also serves as Advisory Board member of Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School.

Eric Wang speaks the following languages:
No languages available.

Eric Wang has prior experience in the following industries:
Phytoscience And Technology , Naturepharm , N And N , Nagasaki University Hospital , Dalian Medical University Hospital

Eric Wang has the following professional experience:
Regenintel Bioscience , Center For Regenerative Therapeutics At Bidmc Harvard Medical School , Skingenix , Phytoscience And Technology , Naturepharm , N And N , Nagasaki University Hospital , Dalian Medical University Hospital .